Intervention Review

Cancer genetic risk assessment for individuals at risk of familial breast cancer

  1. Jennifer S Hilgart2,
  2. Bernadette Coles3,
  3. Rachel Iredale1,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 15 FEB 2012

Assessed as up-to-date: 8 APR 2011

DOI: 10.1002/14651858.CD003721.pub3

How to Cite

Hilgart JS, Coles B, Iredale R. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD003721. DOI: 10.1002/14651858.CD003721.pub3.

Author Information

  1. 1

    University of Glamorgan, Faculty of Health, Sport and Science, Pontypridd, Wales, UK

  2. 2

    Cardiff University, Institute of Medical Genetics, Cardiff, Wales, UK

  3. 3

    Cardiff University, Cancer Research Wales Library, Cardiff, UK

*Rachel Iredale, Faculty of Health, Sport and Science, University of Glamorgan, Pontypridd, Wales, CF37 1DL, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 FEB 2012


Cited in:


This article has been cited by:

  1. 1
    Doreen M. Agnese, Raphael E. Pollock, Breast Cancer Genetic Counseling: A Surgeon’s Perspective, Frontiers in Surgery, 2016, 3,


  2. 2
    Deborah O. Himes, Margaret F. Clayton, Gary W. Donaldson, Lee Ellington, Saundra S. Buys, Anita Y. Kinney, Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information, Journal of Genetic Counseling, 2015,


  3. 3
    Elisabete Weiderpass, Jerzy E. Tyczynski, Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation, Molecular Diagnosis & Therapy, 2015, 19, 6, 351


  4. 4
    M. McAllister, A. Dearing, Patient reported outcomes and patient empowerment in clinical genetics services, Clinical Genetics, 2015, 88, 2
  5. 5
    W. Eijzenga, E. M. A. Bleiker, D. E. E. Hahn, L. E. Van der Kolk, G. N. Sidharta, N. K. Aaronson, Prevalence and detection of psychosocial problems in cancer genetic counseling, Familial Cancer, 2015, 14, 4, 629


  6. 6
    W. Eijzenga, E.M.A. Bleiker, M.G.E.M. Ausems, G.N. Sidharta, L.E. Van der Kolk, M.E. Velthuizen, D.E.E. Hahn, N.K. Aaronson, Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial, Clinical Genetics, 2015, 87, 5
  7. 7
    Dolores Cuevas-Cuerda, Dolores Salas-Trejo, Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain), Familial Cancer, 2014, 13, 2, 301


  8. 8
    Aisha S. Sie, Wendy A. G. van Zelst-Stams, Liesbeth Spruijt, Arjen R. Mensenkamp, Marjolijn J. L. Ligtenberg, Han G. Brunner, Judith B. Prins, Nicoline Hoogerbrugge, More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling, Familial Cancer, 2013,


  9. 9
    Caroline M Benjamin, Lois H Thomas, Heather Skirton, Shanna Gustafson, Jacqueline Coupe, Christine Patch, Rachel Belk, Svetlana Tishkovskaya, Kathleen Calzone, Katherine Payne, Interventions to improve patient access to and utilisation of genetic and genomic counselling services., The Cochrane Library,